Basiliximab Drug Information
A healthcare provider may prescribe basiliximab (Simulect®) to help keep the body from rejecting a newly transplanted kidney. This drug must be used in combination with other anti-rejection medications, and is approved for use in adults and children as young as one year old. It is injected intravenously (through an IV) by your healthcare provider.
This medicine works by weakening the immune system so that your body does not view the new kidney as foreign and try to attack it. Basiliximab is given within two hours after your transplant surgery, followed by a second dose four days later.
Although it is generally a safe and effective drug, not everyone can use basiliximab. Safety information should be reviewed with your healthcare provider before starting treatment to ensure that this is the right product for you. For instance, you may not be able to use this medicine if you are taking certain medications or have an infection.
(Click Basiliximab for more details on this drug, including information on what to expect during treatment, what to do if you miss a dose, and more.)